William Pelham to Double-Blind Method
This is a "connection" page, showing publications William Pelham has written about Double-Blind Method.
Connection Strength
1.102
-
Pelham WE, Altszuler AR, Merrill BM, Raiker JS, Macphee FL, Ramos M, Gnagy EM, Greiner AR, Coles EK, Connor CM, Lonigan CJ, Burger L, Morrow AS, Zhao X, Swanson JM, Waxmonsky JG, Pelham WE. The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. J Consult Clin Psychol. 2022 May; 90(5):367-380.
Score: 0.206
-
Babinski DE, Waxmonsky JG, Waschbusch DA, Humphery H, Pelham WE. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2017 Apr; 27(3):250-257.
Score: 0.142
-
Beery SH, Quay HC, Pelham WE. Differential Response to Methylphenidate in Inattentive and Combined Subtype ADHD. J Atten Disord. 2017 01; 21(1):62-70.
Score: 0.138
-
Pelham WE, Gnagy EM, Sibley MH, Kipp HL, Smith BH, Evans SW, Bukstein O. Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD. J Atten Disord. 2017 01; 21(2):129-136.
Score: 0.138
-
Pelham WE, Waxmonsky JG, Schentag J, Ballow CH, Panahon CJ, Gnagy EM, Hoffman MT, Burrows-MacLean L, Meichenbaum DL, Forehand GL, Fabiano GA, Tresco KE, Lopez-Williams A, Coles EK, Gonz?lez MA. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting. J Atten Disord. 2011 Jan; 15(1):28-35.
Score: 0.090
-
Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005 Jun; 44(6):522-9.
Score: 0.064
-
Fosco WD, Rosch KS, Waxmonsky JG, Pelham WE, Hawk LW. Baseline performance moderates stimulant effects on cognition in youth with ADHD. Exp Clin Psychopharmacol. 2021 Aug; 29(4):302-307.
Score: 0.045
-
Hawk LW, Fosco WD, Colder CR, Waxmonsky JG, Pelham WE, Rosch KS. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition. J Child Psychol Psychiatry. 2018 12; 59(12):1271-1281.
Score: 0.039
-
Pelham WE, Hoza B, Kipp HL, Gnagy EM, Trane ST. Effects of methylphenidate and expectancy of ADHD children's performance, self-evaluations, persistence, and attributions on a cognitive task. Exp Clin Psychopharmacol. 1997 Feb; 5(1):3-13.
Score: 0.036
-
Pelham WE, Carlson C, Sams SE, Vallano G, Dixon MJ, Hoza B. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. J Consult Clin Psychol. 1993 Jun; 61(3):506-515.
Score: 0.028
-
Pelham WE, Murphy DA, Vannatta K, Milich R, Licht BG, Gnagy EM, Greenslade KE, Greiner AR, Vodde-Hamilton M. Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. J Consult Clin Psychol. 1992 Apr; 60(2):282-292.
Score: 0.026
-
Ashare RL, Hawk LW, Shiels K, Rhodes JD, Pelham WE, Waxmonsky JG. Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder. Psychophysiology. 2010 Sep; 47(5):838-45.
Score: 0.022
-
Shiels K, Hawk LW, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE, Waxmonsky JG, Gangloff BP. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2009 Oct; 17(5):291-301.
Score: 0.021
-
Spencer SV, Hawk LW, Richards JB, Shiels K, Pelham WE, Waxmonsky JG. Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol. 2009 Aug; 37(6):805-16.
Score: 0.021
-
Leddy JJ, Waxmonsky JG, Salis RJ, Paluch RA, Gnagy EM, Mahaney P, Erbe R, Pelham WE, Epstein LH. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):127-36.
Score: 0.021
-
Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDERMOTT MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):180-188.
Score: 0.019
-
Daviss WB, Patel NC, Robb AS, McDERMOTT MP, Bukstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):189-198.
Score: 0.019
-
Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, Rancurello M. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar; 44(3):249-57.
Score: 0.016
-
Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB, Comarda A, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hindshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003 Aug; 71(4):713-27.
Score: 0.014